 |
[1] Deng HF,et al.186Re-hedtmp: a new potential therapy of bone tumor .J Nuclear Medicine, 2003,44(5):412
[2] Deng HF,Lin Li,Tan TC,et al.153Sm-Edtmp therapeutic huge bone tumors.J Nuclear Medicine, 2003,44(5):306
[3] Deng HF,Zhang XY,Tang TC.Treatment of metastatic bone pain with strontium-89.J Nuclear Medicine, 2003,44(5)
[4] Lin Li , Liang ZL,Deng HF, et al.Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect.Chinese Medical Journal, 2002,115(7)
[5] Lin Li , Deng HF,Liang ZL,et al.The meseurement of 153Sm-EDTMP bone uptake value by whole-body scintigraphy and its application in individualized treatment dosimetry of bone metastasis.核科学与技术, 2000,-4
[6] Lin Li , Liang ZL, Deng HF,,et al.153SM-EDTMP therapy dosimetry by wholebody scintigraphy.The J of Nuclear Medicine, 2000,41(5S)
[7] 雷勇,马丽莉,牛卫中,杨玉青,邓侯富.新型主放射性骨治疗剂117Snm-TTHMP生物学性能的研究.中华核医学杂志www.lindalemus.com, 2004,23(6)温广华,邓侯富.18F-FDG PET显像在大肠癌诊治中的应用.中国普外基础与临床杂志, 2004,11(2)
[8] 马丽莉,李云春,邓侯富.碘标记表皮生长因子的代谢特性.同位素, 2002,15(3)
[9] 马丽莉,雷勇,邓侯富.肺癌患者18FDG-PET的临床意义.同位素, 2002,15(1)
[10] 胡疏,邓侯富,蒋树斌.153Sm-羟乙基乙二胺三甲撑膦酸（HEDTMP)的动物实验研究.中华核医学杂志, 2002,22(6)
[11] 邓侯富,谭天秩.153Sm-EDTMP治疗骨转移癌应注意的几个问题.中华核医学杂志, 2001,21(3)
[12] 李林,梁正路,邓侯富.153Sm-EDTMP显像测定骨摄取率在个体化治疗剂量计算中的应用.中华核医学杂志, 2001,21(4)
[13] 李林,邓侯富,谭天秩.亲肿瘤显像剂99Tcm(V)-DMSA显像对153Sm-EDTMP治疗骨转移癌的疗效评价.同位素, 2000,13(1)
[14] 邓侯富,谭天秩,张锡英.153Sm-EDTMP治疗肺癌骨转移.中国肺癌杂志, 2000,3(3)
[15] 胡疏,邓侯富.国外放射性核素89Sr治疗骨转移癌的进展.同位素, 2000,13(2)
联系方式:
电话： 028-8522697 邮箱:deng1hf@163.com |
